Remissions after long-term use of romiplostim for immune thrombocytopenia

Haematologica. 2016 Dec;101(12):e476-e478. doi: 10.3324/haematol.2016.151886. Epub 2016 Sep 1.
No abstract available

Keywords: immune thrombocytopenic purpura; platelets; romiplostim; thrombopoietin.

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / pathology
  • Receptors, Fc / therapeutic use*
  • Receptors, Thrombopoietin / agonists
  • Recombinant Fusion Proteins / therapeutic use*
  • Remission Induction
  • Thrombopoietin / therapeutic use*
  • Time Factors
  • Young Adult

Substances

  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • MPL protein, human
  • Thrombopoietin
  • romiplostim